Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Two-State Receptor Model01:29

The Two-State Receptor Model

1.9K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
1.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to 'The environmental neuroactive chemicals list of prioritized substances for human biomonitoring and neurotoxicity testing: A database and high-throughput toxicokinetics approach' [Environ. Res. 2025 (266) 120537].

Environmental research·2026
Same author

Estimation of species- and sex-specific PFAS pharmacokinetics in mice, rats, and non-human primates using a Bayesian hierarchical methodology.

Toxicology and applied pharmacology·2025
Same author

TAME 2.0: expanding and improving online data science training for environmental health research.

Frontiers in toxicology·2025
Same author

The environmental neuroactive chemicals list of prioritized substances for human biomonitoring and neurotoxicity testing: A database and high-throughput toxicokinetics approach.

Environmental research·2024
Same author

Chemistry domain of applicability evaluation against existing estrogen receptor high-throughput assay-based activity models.

Frontiers in toxicology·2024
Same author

Development and application of a systematic and quantitative weighting framework to evaluate the quality and relevance of relative potency estimates for dioxin-like compounds (DLCs) for human health risk assessment.

Regulatory toxicology and pharmacology : RTP·2023
Same journal

A human liver organoid platform for hepatotoxicity assessment: evaluation using reference compounds.

Frontiers in toxicology·2026
Same journal

Predictors of in-hospital mortality in patients with multiple wasp stings in southwest China.

Frontiers in toxicology·2026
Same journal

Establishing scientific confidence: human biological relevance of reconstructed human respiratory epithelium (RHRE) for assessing respiratory effects.

Frontiers in toxicology·2026
Same journal

NAMs for closing knowledge gaps in assessment of respiratory uptake - a PARC project.

Frontiers in toxicology·2026
Same journal

A NAMs-based framework for screening the endocrine-disrupting potential of plastic additives using cross-species molecular docking and <i>Caenorhabditis elegans</i>.

Frontiers in toxicology·2026
Same journal

Pregnancy and lactation exposure to bisphenol S induces ferroptosis via disrupted hepatic lipid metabolism in offspring mice.

Frontiers in toxicology·2026
See all related articles

Related Experiment Video

Updated: Jun 29, 2025

Parallel Interrogation of &#946;-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay
09:03

Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay

Published on: March 10, 2020

12.3K

Optimizing androgen receptor prioritization using high-throughput assay-based activity models.

Ronnie Joe Bever1, Stephen W Edwards2, Todor Antonijevic3

  • 1U.S. Environmental Protection Agency, Washington, DC, United States.

Frontiers in Toxicology
|March 26, 2024
PubMed
Summary
This summary is machine-generated.

This study developed a data-driven method to optimize chemical screening assays, reducing resource needs by 52% while maintaining high sensitivity for endocrine disruptor detection.

Keywords:
androgen receptorcomputational toxicologyendocrine disruptionhighthroughput screeningtiered testing

More Related Videos

Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications
09:39

Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications

Published on: January 27, 2014

12.7K
A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
07:41

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators

Published on: February 20, 2018

8.9K

Related Experiment Videos

Last Updated: Jun 29, 2025

Parallel Interrogation of &#946;-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay
09:03

Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay

Published on: March 10, 2020

12.3K
Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications
09:39

Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications

Published on: January 27, 2014

12.7K
A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
07:41

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators

Published on: February 20, 2018

8.9K

Area of Science:

  • Environmental toxicology
  • Computational toxicology
  • Chemical screening

Background:

  • Computational models aid chemical prioritization for the U.S. EPA's Endocrine Disruptor Screening Program (EDSP).
  • Existing androgen receptor (AR) pathway models require optimization for efficiency and cost-effectiveness.
  • Assay availability and chemical diversity pose challenges for current screening models.

Purpose of the Study:

  • To demonstrate a data processing method for determining optimal minimal assay batteries.
  • To establish a uniform evaluation method for minimal assay batteries against AR pathway models.
  • To integrate chemical cluster analysis into assay battery performance evaluation.

Main Methods:

  • Compared two previously published AR pathway models (11- and 14-assay).
  • Investigated assay subsets to optimize testing strategies for cost and sensitivity.
  • Incorporated chemical structure-based clustering into a multi-stage testing workflow.

Main Results:

  • An expanded 14-assay model showed higher sensitivity for antagonists; the 11-assay model favored agonists.
  • Identified critical assays: 3 for antagonism, 2 for agonism.
  • A minimum of 9 assays are needed for 95% sensitivity for both agonism and antagonism.
  • Chemical clustering reduced the average assays needed per chemical by 52% in a multi-stage workflow.
  • In silico predictions further reduced resource requirements.

Conclusions:

  • A data-driven approach using chemical clustering and multi-mechanism consideration enhances chemical screening efficiency.
  • This case study validates a proof-of-concept for optimizing assay batteries under the EDSP.
  • Efficient screening maximizes chemical throughput and enables data-driven prioritization for further testing.